Gene: SMIM10
Official Full Name: small integral membrane protein 10provided by HGNC
Gene Summary: Predicted to be located in membrane. [provided by Alliance of Genome Resources, Apr 2025]
Catalog Number | Product Name | Species | Gene | Passage ratio | Mycoplasma testing | Price |
---|---|---|---|---|---|---|
KO13927 | SMIM10 Knockout cell line (HeLa) | Human | SMIM10 | 1:3~1:6 | Negative | Online Inquiry |
KO13928 | SMIM10 Knockout cell line (HEK293) | Human | SMIM10 | 1:3~1:6 | Negative | Online Inquiry |
The SMIM10 Gene Knockout Cell Lines are genetically modified cellular models specifically engineered to lack the expression of the SMIM10 gene. This product is crafted through advanced CRISPR/Cas9 gene editing technology, allowing precise and targeted deletion of the SMIM10 gene, which plays a crucial role in various biological processes, including cellular stress responses and immune modulation. By eliminating this gene, researchers can explore its functional relevance and understand its contributions to disease mechanisms, providing an invaluable tool for signaling pathway elucidation and therapeutic target identification.
The key function of the SMIM10 Gene Knockout Cell Lines lies in their ability to facilitate rigorous studies of SMIM10-related cellular behavior and pathology. KOs can be subjected to various assays, including proliferation, migration, and apoptotic studies, drawing correlations between SMIM10 expression and key cellular processes. Furthermore, investigating the implications of SMIM10 deficiency can enhance our understanding of conditions where this gene is implicated, such as certain cancers or inflammatory diseases.
Scientifically, the availability of SMIM10 Gene Knockout Cell Lines bears significant importance for both fundamental research and translational applications. Researchers in academic and clinical laboratories can employ these cell lines to unravel new biological pathways and assess SMIM10’s role in cellular interactions and disease pathogenesis, making them a critical asset for pharmacological screening and development of targeted therapies.
Compared to alternative methods of studying gene function, such as siRNA or overexpression systems, the knockout model provides more definitive insights, allowing scientists to observe the complete absence of the gene function. Additionally, our SMIM10 knockout lines are validated for consistency and reliability, ensuring that researchers obtain reproducible results that they can trust.
In summary, the SMIM10 Gene Knockout Cell Lines represent a valuable resource for investigators looking to probe the intricacies of gene function in health and disease. Combining cutting-edge technology with robust validation processes, our product stands as a testament to our company's commitment to delivering innovative tools that empower researchers and clinicians alike in their quest for knowledge and therapeutic advancements.
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.